- Home
- STIM vs SOPH Comparison
STIM vs SOPH Comparison
Compare STIM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- SOPH
- Stock Information
- Founded
- STIM 2003
- SOPH 2011
- Country
- STIM United States
- SOPH Switzerland
- Employees
- STIM N/A
- SOPH N/A
- Industry
- STIM Medical/Dental Instruments
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STIM Health Care
- SOPH Health Care
- Exchange
- STIM Nasdaq
- SOPH Nasdaq
- Market Cap
- STIM 224.8M
- SOPH 214.9M
- IPO Year
- STIM 2018
- SOPH 2021
- Fundamental
- Price
- STIM $3.36
- SOPH $3.35
- Analyst Decision
- STIM Strong Buy
- SOPH
- Analyst Count
- STIM 2
- SOPH 0
- Target Price
- STIM $7.00
- SOPH N/A
- AVG Volume (30 Days)
- STIM 1.5M
- SOPH 98.2K
- Earning Date
- STIM 08-05-2025
- SOPH 08-05-2025
- Dividend Yield
- STIM N/A
- SOPH N/A
- EPS Growth
- STIM N/A
- SOPH N/A
- EPS
- STIM N/A
- SOPH N/A
- Revenue
- STIM $111,106,000.00
- SOPH $69,688,000.00
- Revenue This Year
- STIM $105.22
- SOPH $16.60
- Revenue Next Year
- STIM $11.89
- SOPH $18.77
- P/E Ratio
- STIM N/A
- SOPH N/A
- Revenue Growth
- STIM 54.17
- SOPH 7.32
- 52 Week Low
- STIM $0.52
- SOPH $2.58
- 52 Week High
- STIM $5.92
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- STIM 39.34
- SOPH 49.45
- Support Level
- STIM $3.13
- SOPH $3.34
- Resistance Level
- STIM $3.51
- SOPH $3.69
- Average True Range (ATR)
- STIM 0.29
- SOPH 0.22
- MACD
- STIM -0.06
- SOPH 0.01
- Stochastic Oscillator
- STIM 19.49
- SOPH 52.77
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.